Ozempic-Like Drugs 'Tentatively' Linked With Sudden Vision Loss Risk

Ozempic-Like Drugs 'Tentatively' Linked With Sudden Vision Loss Risk

Semaglutide, the active ingredient in brand medicines like Ozempic and Wegovy, could raise the risk of a relatively rare eye disease that is a leading cause of vision loss, according to a retrospective study. The research was led by scientists at Harvard University, and it was driven by anecdotal reports from doctors in Boston, who had three patients in their practice taking semaglutide suffer vision loss in just one week. The follow-up analysis is based on the health data of …